Dear Voornaam, Welcome to your weekly Cancer Research UK Research Update email. I’m pleased to share news about Cancer Research Horizons Seed Fund with you today. We know that the pathway to innovation is difficult on multiple fronts, and at present, not enough of our world-leading research is progressing from the lab to the clinic. Many promising innovations are too early in development for industry or investors to engage with, meaning great ideas can stall. Our Cancer Research Horizons Seed Fund bridges that gap in the translational pipeline by investing in promising, early-stage opportunities, worldwide, from within and beyond the Cancer Research UK network. Launching this week, the £15m fund builds on Horizons’ long-term experience of establishing and growing successful startups and companies. We will invest in innovative therapeutics, medtech, and diagnostics, with a broad remit to support projects with potential benefits for people affected by cancer. So if you have a promising innovation that can no longer be funded via traditional research funding routes, or are looking for funds to grow your startup, read on and get in touch with colleagues at Cancer Research Horizons. Our team will support you through the application process and work with you to build a compelling investment proposition. Also, this week registration is now open for the inaugural Black in Cancer Conference in London, 10–11 October. We’ve partnered with Black in Cancer on this important event to bring together scientists, advocacy groups and partners from across the globe to showcase Black excellence in cancer research and medicine. Read on to see what’s in store and register now to secure your place to join us this autumn.
Iain Foulkes Executive Director Research & Innovation CEO Cancer Research Horizons Cancer Research UK |
|
---|
|
---|
|
|
FUNDING AND RESEARCH OPPORTUNITIES |
|
---|
|
---|
| Applications accepted all-year round |
|
---|
|
---|
| Applications accepted all-year round |
|
---|
|
---|
|
|
CALLING ALL RESEARCHERS – APPLY TO OUR CANCER RESEARCH HORIZONS SEED FUND Are you looking to translate your research via a start-up? We provide quick access to early-stage validation, pre-seed and seed capital investment, and just as importantly, expert support throughout the process. Whether you’re looking for £50k or £500k, get in touch to find out how we can support you. |
|
---|
|
---|
|
|
| CALL FOR ABSTRACTS FOR THE BLACK IN CANCER CONFERENCE
We’re welcoming submissions for the inaugural Black in Cancer conference. Don’t miss out on the opportunity to showcase your work by submitting a poster abstract in one of the event’s 3 scientific areas – basic biology, clinical trials and translation. If you’re a postdoc or student, you may also be chosen to present your work as part of the Future Leaders session. Keep up with all the latest conference information by following us on social media at #BiCconf22. |
|
---|
|
---|
|
|
| HEAR THE LATEST AT OUR LUNG CANCER CONFERENCE: 15–17 NOVEMBER Are you ready to make your mark on global lung cancer research? Submit an abstract by 29 July to present your work alongside an impressive line-up of international experts. The latest speakers to join the programme include Nicky McGranahan (University College London), Jian Carrot-Zhang (Memorial Sloan Kettering Cancer Center), Christine Berg (National Institutes of Health) and Gabriella Sozzi (Milan Institute). Join us in Manchester for a packed agenda of cutting-edge science, expert discussion and debates on the big questions in lung cancer research, plus plenty of opportunities to network. Secure your place at our early bird rate and save £60. |
|
---|
|
---|
|
|
UNLOCK YOUR POTENTIAL WITH FREE COACHING Don’t miss out on this unique opportunity to take part in leadership coaching. Join our pro bono programme now to boost the professional and personal skills you need to progress in your research career. This coaching opportunity is now open to mid-career and senior researchers with leadership responsibilities as well as junior group leaders at our institutes and Cancer Research UK-funded fellows. |
|
---|
| FIRST MAP OF MAJOR CHROMOSOMAL CHANGES THAT OCCUR IN CANCER A new framework for understanding patterns of copy number alterations has enabled a set of copy number signatures to be derived from different experimental assays. Christopher Steel (UCL), Nischalan Pillay (UCL), Ludmil Alexandrov (UCSD) and colleagues used AI techniques developed through Cancer Grand Challenges to analyse the genomes of more than 9,800 people with 33 different types of cancer. They identified 21 copy-number signatures that were common to all cancer types.
The copy-number map will be hosted on COSMIC, and the SigProfiler artificial intelligence toolkit is freely available to others in the research community. |
|
---|
|
---|
|
|
5-MINUTE SURVEY: SKIN CANCER RESEARCH The NCRI Skin Group needs your help in setting new strategic research priorities in skin cancer research. They are asking the cancer community to submit information on the most important unanswered questions in this field. |
|
---|
| PREPARING A MANUSCRIPT? DON'T FORGET TO TELL US ABOUT IT Are you preparing a Cancer Research UK-funded research paper for publication? If so, we'd love to hear about it. You can let us know about pending publications via our manuscript notification form. All information will be treated confidentially and won’t be used without consulting you first. Knowing in advance about upcoming publications helps us plan our communications and means we can better talk to our supporters about the amazing work that their donations help fund. |
|
---|
|
---|
|
|
| CRUK early diagnosis research virtual spotlight presenting International Cancer Benchmarking Partnership research, chaired by Yoryos Lyratzopoulos, UCL Online 2:00 PM 27 June 2022 |
|
---|
|
---|
| Technical webinar from the Cancer Research Horizons AstraZeneca Antibody Alliance Laboratory Online 1:30 PM 05 July 2022 |
|
---|
|
---|
| London, UK 05 September 2022 |
|
---|
|
---|
| Empowering the next generation London, UK 10 October 2022 |
|
---|
|
---|
| Portland, Oregon, USA 18 October 2022 |
|
---|
|
---|
| Manchester, UK 15 November 2022 |
|
---|
|
---|
|
|
WHAT DID YOU THINK OF THIS EMAIL? We're always looking for ways to improve. Please give us your feedback by clicking on one of the below images and leaving a comment. |
|
---|
|
---|
|
|
Been forwarded this email? Subscribe to our newsletter to stay up-to-date. |
---|
| |
---|
|
|
|